Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment Questionnaire
Autor: | Glenn T. Stebbins, Kevin R Duque, Adam Margolius, Philip Saleh, Joaquin A. Vizcarra, Kelvin L. Chou, Alberto J. Espay, Diana Hengartner, Galit Kleiner, Hubert H. Fernandez, Alfonso Fasano, Albie Law, Michel Sáenz Farret, Yu-Yan Poon |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Canada medicine.medical_specialty Movement disorders Intraclass correlation Concurrent validity Severity of Illness Index Classical test theory 03 medical and health sciences 0302 clinical medicine Cronbach's alpha Rating scale Surveys and Questionnaires Item response theory Humans Medicine Aged business.industry Reproducibility of Results Parkinson Disease Middle Aged Confidence interval 030104 developmental biology Neurology Physical therapy Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery |
Zdroj: | Movement Disorders. 36:1392-1400 |
ISSN: | 1531-8257 0885-3185 |
DOI: | 10.1002/mds.28507 |
Popis: | Background In patients with Parkinson's disease (PD), sleep, mood, cognitive, autonomic, and other non-motor symptoms may fluctuate in a manner similar to motor symptoms. Objectives To validate a final version of a patient-rated questionnaire that captures the presence and severity of non-motor fluctuations in levodopa-treated PD patients (NoMoFA). Methods We recruited PD subjects from five movement disorders centers across the US and Canada. We assessed the internal consistency, floor and ceiling effects, test-retest reliability, and concurrent validity of NoMoFA. Classical test theory and item response theory methods informed item reduction and Delphi process yielded a final questionnaire. Results Two hundred subjects and their care-partners participated in the study (age: 66.4 ± 9.6 years; disease duration: 9 ± 5.5 years; median Hoehn and Yahr [HY mean Unified Parkinson's Disease Rating Scale (UPDRS) III ON score: 27.4 ± 14.9). Acceptability of the scale was adequate. There were floor effects in 8/28 items. Cronbach's alpha was 0.894. While eight items had "item-to-total" correlations below the cutoff of 0.4, removing these items did not improve Cronbach's alpha. Test-retest reliability was acceptable (intraclass correlation coefficient [ICC] 0.73; 95% confidence interval, 0.64-0.80). Concurrent validity was adequate with all Spearman's rho values comparing NoMoFA score to other measures of parkinsonian severity showing significance and in the expected direction. A final Delphi panel eliminated one item to avoid redundancy. Conclusions The final 27-item self-administered NoMoFA is a valid and reliable questionnaire, capturing both static and fluctuating non-motor symptoms in PD. © 2021 International Parkinson and Movement Disorder Society. |
Databáze: | OpenAIRE |
Externí odkaz: |